SecBot SecBot
Institutional Cluster

MLYS

Mineralys Therapeutics, Inc.
BULLISH
Impact 6/10
Horizonweeks Processed5mo ago
Institutional cluster: 12 buyers, 1 sellers (bullish)
Actionable Insight ▲ Bullish

The breadth and size of this institutional cluster, particularly the $68.2M new position from Point72 and $78.2M addition from Citadel, suggests a catalyst-driven re-rating. Monitor for upcoming clinical data readouts or regulatory milestones for lorundrostat. The 45-day 13F reporting lag means these positions may have already been adjusted; watch for insider trading patterns and upcoming press releases for confirmation.

DirectionBullish
Confidencemedium
Horizonweeks

How the stock moved after the report

BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$23.94
T+0 close · Jun 11, 2026 · via day close
Latest settled
+17.84%
T+60 · $28.21
Vs SPY
+13.44%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 11 $23.94entry
  2. T+1 · 5mo ago −1.34%α −1.88% · $23.62
  3. T+5 · 5mo ago +4.97%α +4.54% · $25.13
  4. T+20 · 4mo ago +20.97%α +19.08% · $28.96
  5. T+60 · 2mo ago +17.84%α +13.44% · $28.21

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

A strong institutional cluster formed in MLYS during Q3 2025, with 12 buyers accumulating $421.7M in net new positions versus only one seller trimming a small $596K stake. The buying is dominated by mega-passive funds (Vanguard, Fidelity, Morgan Stanley) and two quant funds (Citadel, Point72) making large new or doubled positions, suggesting broad conviction in the company's pipeline prospects. The cluster's scale and breadth signal a significant positive re-rating event, likely tied to clinical or regulatory catalysts for Mineralys' hypertension drug lorundrostat.

Key Financial Metrics

Direction
accumulating
Buy Value
$475.6M
Sell Value
$2.4M
Net Flow
$421.7M

Institutional Positions

Net institutional flow: $421.7M

▲ Buyers (12)

InstitutionActionChangePosition ValueValue Δ
Point72NEW+100%$68.2M$68.2M
CitadelDOUBLED+14273.7%$78.4M$78.2M
FidelityDOUBLED+579.4%$78.5M$74.4M
Morgan StanleyDOUBLED+134.3%$52.2M$44.3M
VanguardADD+29.8%$114.5M$83.0M

▼ Sellers (1)

InstitutionActionChangePrev ValueValue Δ
RenTechTRIM-73.2%$2.4M-$596.4K

Key Facts

  • 12 institutional buyers vs 1 seller in Q3 2025
  • Total net buying of $421.7M across 12 funds
  • Vanguard added $83.0M (29.8% share increase), now holds $114.5M
  • Fidelity doubled position (+579.4%), adding $74.4M to $78.5M
  • Citadel added $78.2M (14,274% increase), now holds $78.4M
  • Point72 initiated a new $68.2M position
  • Morgan Stanley doubled (+134.3%), adding $44.3M to $52.2M
  • Only seller: RenTech trimmed $596K (73.2% reduction)
  • 88% of analysts rate the stock Buy or Strong Buy

Financial Impact

12 institutions accumulated $421.7M in net new positions during Q3 2025, with total buyer holdings reaching $475.6M. The single seller reduced holdings by only $596K.

institutional ownershipfloat turnovervaluation

Risk Factors

  • 13F data is 45+ days old; positions may have been partially or fully unwound since quarter-end
  • Clinical-stage biotech carries binary risk from trial outcomes and regulatory decisions
  • Dominance of mega-passive funds (Vanguard, Fidelity, Schwab) may reflect index rebalancing rather than active conviction

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-MLYS-2025-Q3

Track record

35 reports on MLYS

Performance horizon

3 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +20.53% at T+20 after the Sep 24, 2026 report. 4 of 9 went positive at some point.

Filters
  1. Nov 8, 20268d ago Press Release Bullish 6/10 Entry $15.81 settles Dec 8
  2. Nov 4, 202612d ago 8-K Neutral 4/10 Entry $15.24 settles Dec 4
  3. Nov 3, 202613d ago Institutional Cluster Neutral 2/10 Entry $15.99 settles Dec 2
  4. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $18.18 settles Nov 30
  5. Oct 28, 202619d ago Press Release Bullish 6/10 Entry $21.38 settles Nov 25
  6. Oct 20, 202627d ago 3 Neutral 2/10 Entry $21.10 settles Nov 18
  7. Oct 20, 202627d ago 3 Neutral 2/10 Entry $21.10 settles Nov 18
  8. Oct 19, 202628d ago 8-K Neutral 2/10 Entry $21.58 settles Nov 17
  9. Oct 13, 20264w ago 144 Neutral 3/10 Entry $20.76 to $16.16 ▼ −22.16% −20.89% vs SPY
  10. Sep 30, 20266w ago 144 Neutral 3/10 Entry $23.72 to $21.24 ▼ −10.46% −11.16% vs SPY
Showing 10 of 35

US Market Status

Market Closed · Opens in 8h 10m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 11, 2026